𝔖 Bobbio Scriptorium

✦ LIBER ✦

Re: Tadalafil for Prevention of Erectile Dysfunction After Radiotherapy for Prostate Cancer: The Radiation Therapy Oncology Group [0831] Randomized Clinical Trial

✍ Scribed by Langille, Gavin M.; Kovac, Jason R.; Ramasamy, Ranjith; Dupree, James M.; Lipshultz, Larry I.

Book ID: 125832839
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 57 KB
Volume: 66
Category: Article
ISSN: 0302-2838
DOI: 10.1016/j.eururo.2014.06.029

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Topical Hyaluronic Acid vs. Standard of

Topical Hyaluronic Acid vs. Standard of Care for the Prevention of Radiation Dermatitis After Adjuvant Radiotherapy for Breast Cancer: Single-Blind Randomized Phase III Clinical Trial

✍ Chelsea Pinnix; George H. Perkins; Eric A. Strom; Welela Tereffe; Wendy Woodward 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Topical Hyaluronic Acid vs. Standard of

Topical Hyaluronic Acid vs. Standard of Care for the Prevention of Radiation Dermatitis After Adjuvant Radiotherapy for Breast Cancer: Single-Blind Randomized Phase III Clinical Trial

✍ Horst, K.C.; Lapole, J. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 54 KB

The effect of short term neo-adjuvant an

The effect of short term neo-adjuvant androgen deprivation on erectile function in patients treated with external beam radiotherapy for localised prostate cancer: An analysis of the 4- versus 8-month randomised trial (Irish Clinical Oncology Research Group 97-01)

✍ Patricia E. Daly; Mary T. Dunne; Carmel M. O’Shea; Marie A. Finn; John G. Armstr 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 273 KB

Radiation dose delivered to the proximal

Radiation dose delivered to the proximal penis as a predictor of the risk of erectile dysfunction after three-dimensional conformal radiotherapy for localized prostate cancer: Wernicke AG, Valicenti R, Dieva K, Houser C, Pequignot E, Department of Radiation Oncology, Jefferson Medical College and Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA

✍ Michael Zelefsky 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Commentary on “Surrogate endpoints for p

Commentary on “Surrogate endpoints for prostate cancer-specific mortality after radiotherapy and androgen suppression therapy in men with localized or locally advanced prostate cancer: An analysis of 2 randomized trials.” A.V. D'Amico, M.H. Chen, M. de Castro, M. Loffredo, D.S. Lamb, A. Steigler, P.W. Kantoff, J.W. Denham, Department of Radiation Oncology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, MA, USA

✍ Trump, Donald L. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Commentary on “Is biochemical response m

Commentary on “Is biochemical response more important than duration of neoadjuvant hormone therapy before radiotherapy for clinically localized prostate cancer? An analysis of the 3- vs. 8-month randomized trial”. Alexander A, Crook J, Jones S, Malone S, Bowen J, Truong P, Pai H, Ludgate C, Radiation Therapy Program, British Columbia Cancer Agency, Vancouver Island Centre, University of British Columbia, Victoria, BC, Canada: Int J Radiat Oncol Biol Phys 2010;76:23–30

✍ Alexander Gottschalk 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 68 KB